Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 330

1.

Reply to Halfon et al.

Miller V, Harrington P, Howe A, Kieffer T, Lennerstrand J, Lenz O, Lontok E, McPhee F, Mo H, Parkin N, Pilot-Matias T.

Hepatology. 2016 Apr 26. doi: 10.1002/hep.28615. [Epub ahead of print] No abstract available.

PMID:
27113118
2.

Bortezomib-induced proinflammatory macrophages as a potential factor limiting anti-tumour efficacy.

Beyar-Katz O, Magidey K, Ben-Tsedek N, Alishekevitz D, Timaner M, Miller V, Lindzen M, Yarden Y, Avivi I, Shaked Y.

J Pathol. 2016 Apr 1. doi: 10.1002/path.4723. [Epub ahead of print]

PMID:
27037906
3.

Nutrient release and ammonium sorption by poultry litter and wood biochars in stormwater treatment.

Tian J, Miller V, Chiu PC, Maresca JA, Guo M, Imhoff PT.

Sci Total Environ. 2016 May 15;553:596-606. doi: 10.1016/j.scitotenv.2016.02.129. Epub 2016 Mar 22.

PMID:
26938322
4.

Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis.

Sanyal AJ, Miller V.

Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00235-3. doi: 10.1053/j.gastro.2016.02.044. [Epub ahead of print] No abstract available.

PMID:
26924092
5.

Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis.

Campregher PV, Pereira Wde O, Lisboa B, Puga R, Helman R, Miyagi M, da Mata EH, Datoguia TS, Velloso ED, Bacal NS, Ross JS, Ali S, Miller V, Costa FF, Hamerschlak N, Santos FP.

Mol Cancer. 2015 Nov 19;14(1):197. doi: 10.1186/s12943-015-0471-5.

6.

Microsecond-pulsed dielectric barrier discharge plasma stimulation of tissue macrophages for treatment of peripheral vascular disease.

Miller V, Lin A, Kako F, Gabunia K, Kelemen S, Brettschneider J, Fridman G, Fridman A, Autieri M.

Phys Plasmas. 2015 Dec;22(12):122005. Epub 2015 Oct 20.

PMID:
26543345
7.

Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.

Cherian S, McCullouch V, Miller V, Dougherty K, Fromm JR, Wood BL.

Cytometry B Clin Cytom. 2015 Nov 3. doi: 10.1002/cyto.b.21336. [Epub ahead of print]

PMID:
26525770
8.

Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.

Kucine N, Marubayashi S, Bhagwat N, Papalexi E, Koppikar P, Sanchez Martin M, Dong L, Tallman MS, Paietta E, Wang K, He J, Lipson D, Stephens P, Miller V, Rowe JM, Teruya-Feldstein J, Mullighan CG, Ferrando AA, Krivtsov A, Armstrong S, Leung L, Ochiana SO, Chiosis G, Levine RL, Kleppe M.

Blood. 2015 Nov 26;126(22):2479-83. doi: 10.1182/blood-2015-03-635821. Epub 2015 Oct 6.

PMID:
26443624
9.

Dequalinium blocks macrophage-induced metastasis following local radiation.

Timaner M, Bril R, Kaidar-Person O, Rachman-Tzemah C, Alishekevitz D, Kotsofruk R, Miller V, Nevelsky A, Daniel S, Raviv Z, Rotenberg SA, Shaked Y.

Oncotarget. 2015 Sep 29;6(29):27537-54. doi: 10.18632/oncotarget.4826.

10.

Developing a treatment summary and survivorship care plan responsive to African-American breast cancer survivors.

Ashing KT, Lai L, Brown S, McDowell K, Carter D, Smith J, Mitchell E, Santifer RH, Martin V, Betts-Turner B, Fielder O, Miller V.

Psychooncology. 2015 Aug 28. doi: 10.1002/pon.3939. [Epub ahead of print] No abstract available.

PMID:
26315465
11.

Hepatitis C virus drug resistance-associated substitutions: State of the art summary.

Lontok E, Harrington P, Howe A, Kieffer T, Lennerstrand J, Lenz O, McPhee F, Mo H, Parkin N, Pilot-Matias T, Miller V.

Hepatology. 2015 Nov;62(5):1623-32. doi: 10.1002/hep.27934. Epub 2015 Jul 30. Review.

PMID:
26095927
12.

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

Skoulidis F, Byers LA, Diao L, Papadimitrakopoulou VA, Tong P, Izzo J, Behrens C, Kadara H, Parra ER, Canales JR, Zhang J, Giri U, Gudikote J, Cortez MA, Yang C, Fan Y, Peyton M, Girard L, Coombes KR, Toniatti C, Heffernan TP, Choi M, Frampton GM, Miller V, Weinstein JN, Herbst RS, Wong KK, Zhang J, Sharma P, Mills GB, Hong WK, Minna JD, Allison JP, Futreal A, Wang J, Wistuba II, Heymach JV.

Cancer Discov. 2015 Aug;5(8):860-77. doi: 10.1158/2159-8290.CD-14-1236. Epub 2015 Jun 11.

13.

Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases.

Subbiah V, Berry J, Roxas M, Guha-Thakurta N, Subbiah IM, Ali SM, McMahon C, Miller V, Cascone T, Pai S, Tang Z, Heymach JV.

Lung Cancer. 2015 Jul;89(1):76-9. doi: 10.1016/j.lungcan.2015.04.004. Epub 2015 Apr 22.

PMID:
25982012
14.

Self-hypnosis for intrapartum pain management in pregnant nulliparous women: a randomised controlled trial of clinical effectiveness.

Downe S, Finlayson K, Melvin C, Spiby H, Ali S, Diggle P, Gyte G, Hinder S, Miller V, Slade P, Trepel D, Weeks A, Whorwell P, Williamson M.

BJOG. 2015 Aug;122(9):1226-34. doi: 10.1111/1471-0528.13433. Epub 2015 May 11.

15.

Letter: efficacy of hypnotherapy in one thousand patients with irritable bowel syndrome--authors' reply.

Miller V, Carruthers H, Morris J, Hasan SS, Archbold S, Whorwell PJ.

Aliment Pharmacol Ther. 2015 Jun;41(11):1223-4. doi: 10.1111/apt.13205. No abstract available.

PMID:
25939472
16.

Promoting sex and gender to optimize clinical research and healthcare delivery.

Veldhuis K, Miller V, Kublickiene K.

Maturitas. 2015 Jul;81(3):333-4. doi: 10.1016/j.maturitas.2015.03.027. Epub 2015 Apr 13. No abstract available.

PMID:
25934602
17.

Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis.

Voloshin T, Alishekevitz D, Kaneti L, Miller V, Isakov E, Kaplanov I, Voronov E, Fremder E, Benhar M, Machluf M, Apte RN, Shaked Y.

Mol Cancer Ther. 2015 Jun;14(6):1385-94. doi: 10.1158/1535-7163.MCT-14-0969. Epub 2015 Apr 17.

PMID:
25887886
18.

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.

Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ.

Aliment Pharmacol Ther. 2015 May;41(9):844-55. doi: 10.1111/apt.13145. Epub 2015 Mar 4.

PMID:
25736234
19.

Improving evidence developed from population-level experience with targeted agents.

McClellan MB, Daniel GW, Dickson D, Perlmutter J, Berger DP, Miller V, Nussbaum S, Malin J, Romine MH, Schilsky RL.

Clin Pharmacol Ther. 2015 May;97(5):478-87. doi: 10.1002/cpt.90. Epub 2015 Apr 3. Review.

PMID:
25676878
20.

How can we exploit the brain's ability to repair itself?

Miller V, Gomez-Nicola D.

Expert Rev Neurother. 2014 Dec;14(12):1345-8. doi: 10.1586/14737175.2014.985659.

PMID:
25427149
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk